Journal of Animal Science and Biotechnology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2019-06-14 Rtase

审稿速度:3.0 | 投稿命中率:50.0
经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas

158 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2018-06-16 Rtase

审稿速度:3.0 | 投稿命中率:25.0
经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!

250 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2017-12-08 小虾米005

审稿速度:3.0 | 投稿命中率:25.0
经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。

327 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2016-01-21 大耳朵

审稿速度:3.0 | 投稿命中率:5.0
经验分享：审稿时间很久，效率太差，而且很难中

365 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2015-06-10 shijian1109

一期几篇？

338 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2015-02-10 271519856qq

Author(s): Zhongguo xu mu shou yi xue hu

315 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2015-02-10 271519856qq

Current Indexing Status: Not currently indexed for MEDLINE

328 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2015-02-10 271519856qq

不是SCI哦

363 0

[GetPortalCommentsPageByObjectIdResponse(id=572257, encodeId=690c5e2257f2, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时if509/152=3.3487，以后能控制国人文章数量，减少关系文章就是一本不错的期刊，终将取代jas, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Fri Jun 14 00:00:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558043, encodeId=abca558043a0, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：实时if382/127=3.0078.之前不看好这个杂志.可能刚创刊关系文章比较多!就目前综述占比下降.年文章数逐渐增多来看.以后还是个很有潜力杂志.长期维持3分以上!最近中了一篇3个审稿人.还是折腾了小半年.对实验性文章要求还是高!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jun 16 00:00:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549834, encodeId=a5325498348d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：现在这本刊是OA，SCI收录的，可惜不是MEDLINE收录，目前刊载量在逐渐增大，可接收稿件的研究方向范围也比较广，Research论文比例越来越高，命中率还行，可能目前审稿周期还是偏长，一般投稿到接收为4~5个月，刊载国内文章占比还行40%左右，不过国内投稿率应该也高哈。中不中就看文章质量了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc492218363, createdName=小虾米005, createdTime=Fri Dec 08 11:02:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518637, encodeId=142f51863e63, content=审稿速度:3.0 | 投稿命中率:5.0 经验分享：审稿时间很久，效率太差，而且很难中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=58381655841, createdName=大耳朵, createdTime=Thu Jan 21 15:26:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512434, encodeId=aef2512434e8, content=一期几篇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a368980, createdName=shijian1109, createdTime=Wed Jun 10 12:52:00 CST 2015, time=2015-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509721, encodeId=b381509e212f, content=Author(s): Zhongguo xu mu shou yi xue hu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:21:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509720, encodeId=e6c1509e2042, content=Current Indexing Status: Not currently indexed for MEDLINE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:20:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509719, encodeId=1a10509e1903, content=不是SCI哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=421854282, createdName=271519856qq, createdTime=Tue Feb 10 00:17:00 CST 2015, time=2015-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506885, encodeId=02185068859d, content=季刊！时间太久了吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=123456, createdTime=Sat Oct 18 18:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]

2014-10-18 123456

季刊！时间太久了吧！

373 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务